|Articles|September 30, 2022
NeurologyLive® Friday 5 — September 30, 2022
Author(s)NeurologyLive® Staff
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 23, 2022.
Advertisement
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
1: Assessing Lecanemab’s Effect in Early Alzheimer Disease: Sharon Cohen, MD, FRCPC
The neurologist and assistant professor at the University of Toronto provided insight on the recently announced positive topline findings from the phase 3 Clarity AD study of lecanemab (BAN2401) in early Alzheimer disease.
2: Peer Exchange: The Future of Multiple Sclerosis Treatment
In this NeurologyLive® Peer Exchange episode, Ahmed Obeidat, MD, PhD; Benjamin Greenberg, MD; and Hesham Abboud, MD, share their hopes about the evolution of future multiple sclerosis care and express their gratitude for the next generation of neurologists.
3: NeuroVoices: Emma Ciafaloni, MD, on the Vast Expansion of Innovative Approaches to Duchenne Muscular Dystrophy
In the latest edition of our in-depth Q&A series, the professor of neurology and pediatrics at the University of Rochester Medical Center provided insight on the emerging therapies and advancements for treating patients with Duchenne muscular dystrophy.
4: State of Insomnia Care and Overcoming Inconsistencies in the Traditional Care Strategies
Ashgan Elshinawy, DO, a pulmonologist at Penn Medicine, assessed the current ways to treat patients with insomnia and the areas of needed improvement. Elshinawy provided insight on treatments such as cognitive behavioral therapy, the need for patience when managing the condition, and the potential to overhaul care going forward.
5: American Association of Neuromuscular & Electrodiagnostic Medicine 2022 Annual Meeting
The American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting may be over, but the latest in neuromuscular, musculoskeletal, and electrodiagnostic medicine is all included in NeurologyLive®'s coverage, which has continued through the week.
—————————————————
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
NeurologyLive® Friday 5 — September 12, 2025September 12th 2025
Expanding the Alzheimer Drug Development PipelineSeptember 12th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
FDA Hands Complete Response Letter to SL1009 for Pyruvate Dehydrogenase Complex Deficiency
2
Expanding the Alzheimer Drug Development Pipeline
3
Patient-Reported Study Identifies Common Symptoms and Timing During Migraine Prodrome
4
NeurologyLive® Friday 5 — September 12, 2025
5
